These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 6976062

  • 21. Specific activation of human peripheral blood gamma/delta + lymphocytes by sonicated antigens of Mycobacterium tuberculosis: role in vitro in killing human bladder carcinoma cell lines.
    Wang MH, Chen YQ, Gercken J, Ernst M, Böhle A, Flad HD, Ulmer AJ.
    Scand J Immunol; 1993 Sep; 38(3):239-46. PubMed ID: 8356400
    [Abstract] [Full Text] [Related]

  • 22. Modulation by cis-diamminedichloroplatinum (II) of the susceptibilities of human T24 lined and freshly separated autologous urinary bladder transitional carcinoma cells to peripheral blood lymphocytes and lymphokine activated killer cells.
    Mizutani Y, Nio Y, Yoshida O.
    J Urol; 1992 Feb; 147(2):505-10. PubMed ID: 1732632
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Expression of the cellular immune response during tumor development in an animal model of bladder cancer.
    Droller MJ, Gomolka D.
    J Urol; 1982 Dec; 128(6):1385-9. PubMed ID: 7154212
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y, Yoshida O, Bonavida B.
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. In vitro enhancement of natural and antibody-dependent lymphocyte-mediated cytotoxicity against tumor target cells by interferon.
    Droller MJ, Borg H, Perlmann P.
    Cell Immunol; 1979 Oct; 47(2):248-60. PubMed ID: 487447
    [No Abstract] [Full Text] [Related]

  • 35. Lymphocyte response to transitional cell carcinoma: peripheral cytotoxicity and local tumor infiltration.
    Jones LW, O'Toole C.
    J Urol; 1977 Dec; 118(6):974-7. PubMed ID: 926279
    [Abstract] [Full Text] [Related]

  • 36. Sensitization of lymphocytes against pooled allogeneic cells. I. Generation of cytotoxicity against autologous human lymphoblastoid cell lines.
    Zarling JM, Bach FH.
    J Exp Med; 1978 May 01; 147(5):1334-40. PubMed ID: 206649
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Correlation of primary tumor bed lymphocytic infiltration and peripheral lymphocyte cytotoxicity in patients with transitional cell carcinoma.
    Jones LW, O'Toole C.
    Natl Cancer Inst Monogr; 1978 Dec 01; (49):183-5. PubMed ID: 748770
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.